神經醯胺 × 膽固醇 × 脂肪酸

Barrier Lipid Trio

閱讀模式

簡明版：使用要點、注意事項與迷思澄清。

簡明衛教

概述

生理脂質比例修復屏障的黃金組合。

適用膚況・有效濃度

依產品標示與耐受逐步建立；嚴重膚況請皮膚科評估。

使用建議

依標示與 patch test；新產品一次導入一種活性。

副作用・禁忌・就醫提醒

若紅腫、滲液、快速惡化應停用人新產品並就醫。

參考文獻與出處

[1]期刊觀察研究
Walimbe AS; Waskow E; Mackay L; Miller M. 2025. Expanded Clinical Phenotype and the Role of Untargeted Metabolomics Analysis in Confirming the Diagnosis of Sodium-Dependent Multivitamin Transporter Deficiency.. American journal of medical genetics. Part A
DOI: 10.1002/ajmg.a.64014PMID: 39898461取用：2026-06-13
[2]期刊觀察研究
Zhao J; Liu Y; Sun Z; Wang L. 2024. Effects of Different Levels of Carbohydrates on Growth Performance, Hepatic and Intestinal Health, and Intestinal Microflora of Juvenile Pikeperch (Sander lucioperca).. Aquaculture nutrition
DOI: 10.1155/2024/8450154PMID: 39555508取用：2026-06-13
[3]期刊觀察研究
Violi F; Pignatelli P; Castellani V; Carnevale R. 2023. Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis.. Blood reviews
DOI: 10.1016/j.blre.2022.100998PMID: 35985881取用：2026-06-13
[4]期刊觀察研究
Galliano MF; Tfayli A; Dauskardt RH; Payre B. 2021. Comprehensive characterization of the structure and properties of human stratum corneum relating to barrier function and skin hydration: modulation by a moisturizer formulation.. Experimental dermatology
DOI: 10.1111/exd.14331PMID: 33811391取用：2026-06-13
[5]期刊觀察研究
Taiwo B; Murphy RL; Katlama C. 2010. Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results.. Drugs
DOI: 10.2165/11538020-000000000-00000PMID: 20731472取用：2026-06-13
[6]期刊觀察研究
Palter DP; Corbera EF; Tiraboschi JM. 2009. [Etravirine in highly treatment-experienced patients].. Enfermedades infecciosas y microbiologia clinica
DOI: 10.1016/S0213-005X(09)73213-6PMID: 20116622取用：2026-06-13

本網站內容為一般保養與成分衛教，非醫療診斷或治療建議。化粧品不得宣稱醫療效能；若皮膚問題持續或惡化，請洽皮膚科醫師。

證據等級標示供消費者理解文獻型態，不代表對特定品牌或產品之療效背書；我們不推薦特定醫美療程或處方用藥。